FuelCell Energy stock rallies after announcing order with Exxon Mobil for carbon capture technology, support
Shares of FuelCell Energy Inc. (FCEL) charged up 2.7% in premarket trading Monday, after the maker of fuel cell technology platforms said it received an order from Exxon Mobil Corp. (XOM) affiliate ESSO Nederland B.V. for equipment and support needed to implement a potential demonstration of carbon capture at an Exxon Mobil facility. The company said that while Exxon Mobil hasn't made a final investment decision, the order advances equipment procurement and engineering work needed as it takes steps toward commercializing its carbon-capture technology. "FuelCell Energy continues to gain confidence in achieving large scale commercialization of FuelCell Energy's carbonate technology for industrial and commercial point source carbon capture," said FuelCell Chief Executive Officer Jason Few. "We believe that this technology will address one of the largest environmental challenges of today, CO2 emissions from industrial and commercial exhaust streams and power generation." The stock, which had closed last Wednesday at a 2 1/2-year low of $1.80, has tumbled 51.3% over the past three months while the S&P 500 has gained 1.2%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-01-23 0823ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth